Cellyan Biotechnology (HKPD) Total Debt Growth (1y) (2025)
Cellyan Biotechnology (HKPD) Total Debt Growth (1y) (2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 105.15 Bn | 101.18 Bn | 4.04 Bn | 16.01% |
| 2 | Cencora | 60.58 Bn | 58.40 Bn | 3.59 Bn | 57.65% |
| 3 | Cardinal Health | 53.81 Bn | 49.87 Bn | 2.50 Bn | 16.11% |
| 4 | Henry Schein | 9.71 Bn | 9.57 Bn | 1.07 Bn | 66.65% |
| 5 | Akso Health | 3.28 Bn | 3.28 Bn | - | -82.47% |
| 6 | 111 | 651.73 Mn | 572.63 Mn | 23.58 Mn | 18.04% |
| 7 | Accendra Health | 248.02 Mn | -88.86 Mn | 278.03 Mn | 8.00% |
| 8 | Edap Tms | 230.14 Mn | 215.14 Mn | 8.15 Mn | 141.68% |
| 9 | VitaNova Life Sciences | 11.51 Mn | 11.01 Mn | 316,343.00 | - |
| 10 | Cellyan Biotechnology | 4.19 Mn | 3.44 Mn | - | 597.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 597.31% |
| Mar 31, 2025 | 15.80% |